Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 3
1974 1
1975 2
1977 4
1978 2
1979 2
1980 2
1981 1
1983 1
1984 3
1985 5
1986 6
1987 7
1988 4
1989 6
1990 4
1991 2
1992 8
1993 8
1994 7
1995 9
1996 8
1997 11
1998 6
1999 5
2000 7
2001 3
2003 8
2004 4
2005 5
2006 1
2007 3
2008 2
2009 1
2017 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
Ureterocolic fistula.
Noordzij JW, Garibyan H, Kurth KH. Noordzij JW, et al. Among authors: kurth kh. Eur Urol. 1991;19(1):85-6. doi: 10.1159/000473587. Eur Urol. 1991. PMID: 2007424 No abstract available.
Molecular pathology of non-invasive urothelial carcinomas (part I).
Helpap B, Schmitz-Dräger BJ, Hamilton PW, Muzzonigro G, Galosi AB, Kurth KH, Lubaroff D, Waters DJ, Droller MJ. Helpap B, et al. Among authors: kurth kh. Virchows Arch. 2003 Apr;442(4):309-16. doi: 10.1007/s00428-002-0748-0. Epub 2003 Feb 11. Virchows Arch. 2003. PMID: 12715166 Review.
Quality-of-life assessment in bladder cancer.
van der Veen JH, van Andel G, Kurth KH. van der Veen JH, et al. Among authors: kurth kh. World J Urol. 1999 Aug;17(4):219-24. doi: 10.1007/s003450050136. World J Urol. 1999. PMID: 10460404 Review. No abstract available.
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.
Sylvester RJ, van der Meijden A, Witjes JA, Jakse G, Nonomura N, Cheng C, Torres A, Watson R, Kurth KH. Sylvester RJ, et al. Among authors: kurth kh. Urology. 2005 Dec;66(6 Suppl 1):90-107. doi: 10.1016/j.urology.2005.06.135. Urology. 2005. PMID: 16399418 Review.
152 results